Get started
Author

Kazunori Takagi

Bioequivalence Evaluations of Generic Dry Powder Inhaler Drug Products: Similarities and Differences Between Japan, USA, and the European Union
2016 · Ryosuke Kuribayashi, Toru Yamaguchi, et al. · Clinical Pharmacokinetics · 19
Modernization and Strengthening of Bioequivalence Guidelines in Japan
2020 · Ryosuke Kuribayashi, Toru Yamaguchi, et al. · Clinical Pharmacokinetics · 12
Exposure of Drugs for Hypertension, Diabetes, and Autoimmune Disease During Pregnancy and Perinatal Outcomes: An Investigation of the Regulator in Japan
2015 · Ryosuke Sato, Mutsuhiro Ikuma, et al. · Medicine · 11
Current Regulation for Bioequivalence Evaluations of Generic Ophthalmic Dosage Forms in Japan
2020 · Aya Myoenzono, Ryosuke Kuribayashi, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 6
Current Understanding of the Equivalence Evaluations for In Vitro Tests on Generic Dry Powder Inhaler Drug Products in Japan
2019 · Ryosuke Kuribayashi, Aya Myoenzono, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 5
Similarities and Differences of International Practices and Procedures for the Regulation for Active Substance Master Files/Drug Master Files of Human Use: Moving Toward Regulatory Convergence
2016 · Maki Matsuhama, Tomoko Takishita, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 4
PDF
Generic Drug Product Development in Japan: Regulatory Updates During 2014–2019 and the Future
2021 · Miho Kasuga, Ryosuke Kuribayashi, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 3
Bioequivalence of Generic Semi-solid Topical Dermatological Drug Products: Scientific and Regulatory Perspective from Japan’s 2025 Guidelines
2026 · Hiroyuki Yoshida, Yasuhiro Abe, et al. · Therapeutic Innovation & Regulatory Science
Comparative bioavailability of a new sustained-release theophylline tablet.
1987 · K Takagi, T Watanabe, et al. · PubMed
Works count: 9
Citation count: 60
H-index: 5
I10-index: 3
Year
Topic
Type